P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
批准号:
7350950
负责人:
Arthur M. BUCHBERG
金额:
$23.89万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2011-02-28
关键词:
AffectApoptosisApoptoticAttenuatedBindingBiological AssayBreastBreast CarcinomaCell Cycle ArrestCell Cycle CheckpointCell Cycle RegulationCellsCellular StressCo-ImmunoprecipitationsDNA DamageDNA Microarray ChipDNA Microarray formatDisruptionElectrophoretic Mobility Shift AssayElementsGene AmplificationGene Expression ProfilingGene TargetingGenesGenetic TranscriptionGenotoxic StressGoalsHumanKnock-outMDM2 geneMalignant NeoplasmsMeasuresMediatingN-terminalNeuroblastomaOvarianPPM1D genePathway interactionsPatternPhosphorylationPhosphotransferasesPlayPolymerase Chain ReactionProtein p53Protein phosphataseReactionReporter GenesResearch PersonnelRoleSignal TransductionStressTP53 geneTestingTimeTranscription CoactivatorTranscriptional ActivationTransfectionTransgenesTumor Cell LineTumor Suppressor ProteinsWestern Blottingabstractingbasechemotherapeutic agentchromatin immunoprecipitationin vivoneoplastic cellnovel therapeuticsovarian neoplasmp53 Signaling Pathwayp53-binding proteinprogramspromoterresponsetranscription factortumor
中文摘要
P53介导的Gl/M检查点控制被PPM 1D改变
p53肿瘤抑制蛋白是一种序列特异性转录因子,其调节细胞对以下的应答:
遗传毒性应激和其他形式的细胞应激。PPM 1D(正式名称为Wipl)是转录激活的,
以p53依赖的方式对遗传毒性应激的反应。它编码一种蛋白磷酸酶,靶向应激诱导的
激酶p38 MAPK,其破坏p38 MAPK-p53信号通路。这是与改变,
p53蛋白N端磷酸化模式。N-末端磷酸化对于p53蛋白
作为一种制约因素。我们和其他人已经表明,PPM ID的强制外源表达减弱了
对DNA损伤剂的凋亡反应。降低人肿瘤细胞中的PPM 1D,
由于基因扩增而表达它增强了对化疗剂的凋亡反应。这与
促凋亡Bax基因表达水平的变化。本项目的目的是阐明促凋亡Bax基因表达水平的机制。
PPM 1D在调节p53转录活性中的作用。有待验证的假设是,
PPM 1D对p38 MAPK-p53信号通路的破坏影响p53介导的应答基因转录
参与细胞周期检查点控制和/或凋亡。具体目标如下:1)确定是否
PPM ID介导的p38 MAPK-p53信号转导的破坏改变了p53蛋白和p53应答蛋白之间的相互作用
下游靶基因的元件。2)为了确定PPMID介导的p38 MAPK-p53信号转导的破坏是否
改变p53蛋白与转录辅激活因子的相互作用。3)为了识别和表征基因,
通过PPM ID介导的p38 MAPK-p53信号传导途径的破坏改变表达。
摘要:PPM 1D是p53网络中的一个新成员,目前我们对它知之甚少。PPM1D
在携带野生型p53基因的人乳腺癌、卵巢癌和神经母细胞瘤肿瘤中,p53基因经常被扩增。这
该项目将提供有关PPM 1D在参与细胞周期的p53网络中发挥作用的新信息
控制和凋亡,并阐明了这一行动的机制基础。
英文摘要
P53-Mediated Gl/M Checkpoint Controls Altered by PPM1D
The p53 tumor suppressor protein is a sequence-specific transcription factor that modulates the response of cells to
genotoxic stress and other forms of cellular stress. PPM1D (formally called Wipl) is transcriptionally-activated in
response to genotoxic stress in a p53-dependent manner. It encodes a protein phosphatase that targets the stress induced
kinase p38MAPK which disrupts the p38MAPK-p53 signalingpathway. This is correlated with alterations in the
pattern of N-terminal phosphorylation on p53 protein. N-terminal phosphorylation is important for p53 protein to
function as a trariscriptional factor. We and others have shown that forced exogenous expression of PPM ID attenuates
the apoptotic response to DNA-damaging agents. Decreasing PPM1D in human tumor cells that constitutively over
express it due to gene amplification enhances the apoptotic response to chemotherapeutic agents. This is correlated with
changes,in the level of expression of the pro-apoptotic Bax gene.The goal of this project is to elucidate the mechanistic
basis and the role that PPM1D plays in modulatingthe transcriptional activity of p53.The hypothesis to be tested is that
disruption of the p38MAPK-p53 signaling pathway by PPM1D affects p53-mediated transcription of responsive genes
involved in cell cycle checkpoint control and/or apoptosis. The Specific Aims are the following: 1) To determine if
PPM ID-mediated disruptionof p38MAPK-p53 signalingalters the interaction between p53 protein and p53-responsive
elements of downstream target genes. 2) To determine if PPMID-mediated disruptionof p38MAPK-p53 signaling
alters the interaction of p53 protein with transcriptional coactivators. 3) To identify and characterize genes whose
expression is altered by PPM ID-mediated disruption of the p38MAPK-p53 signaling pathway.
Lay Abstract: PPM1D is a new player in the p53 network about which we know very little at present. The PPM1D
gene is often amplified in human breast, ovarian and neuroblastoma tumors that harbor a wild type p53 gene. This
project will provide new informationregarding the role that PPM1D plays in the p53 network involved in cell cycle
control and apopotosis and elucidate the mechanistic basis for this action.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lab Animal
-
批准号:8302936
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2011
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Lab Animal
-
批准号:8084093
-
项目类别:
-
资助金额:$20.91万
-
财政年份:2010
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Sensitized screen to identify cooperating genes involved in pancreatic cancer
-
批准号:7660263
-
项目类别:
-
资助金额:$20.39万
-
财政年份:2009
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Activation of Innate Immunity Effector Cells
-
批准号:7002695
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2003
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Activation of Innate Immunity Effector Cells
-
批准号:7163452
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2003
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6633389
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6712794
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6124693
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6513550
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6377140
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
-
批准号:7568858
-
项目类别:
-
资助金额:$23.89万
-
财政年份:1999
-
负责人:Arthur M. BUCHBERG
-
依托单位:
NOVEL ONCOGENES IN VIRUS INDUCED MYELOID TUMORS
-
批准号:6101894
-
项目类别:
-
资助金额:$29.02万
-
财政年份:1999
-
负责人:Arthur M. BUCHBERG
-
依托单位:
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
-
批准号:7768494
-
项目类别:
-
资助金额:$23.89万
-
财政年份:1999
-
负责人:Arthur M. BUCHBERG
-
依托单位:
NOVEL ONCOGENES IN VIRUS INDUCED MYELOID TUMORS
-
批准号:6268994
-
项目类别:
-
资助金额:$27.96万
-
财政年份:1998
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE MURINE ALL-1 GENE--TUMORIGENESIS AND DEVELOPMENT
-
批准号:6102571
-
项目类别:
-
资助金额:$24.92万
-
财政年份:1998
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE MURINE ALL-1 GENE--TUMORIGENESIS AND DEVELOPMENT
-
批准号:6237085
-
项目类别:
-
资助金额:$24.09万
-
财政年份:1997
-
负责人:Arthur M. BUCHBERG
-
依托单位:
NOVEL ONCOGENES IN VIRUS INDUCED MYELOID TUMORS
-
批准号:6236418
-
项目类别:
-
资助金额:$26.88万
-
财政年份:1997
-
负责人:Arthur M. BUCHBERG
-
依托单位:
INVOLVEMENT OF THE EVI-2 LOCUS IN MYELOID LEUKEMIA
-
批准号:2099261
-
项目类别:
-
资助金额:$19.78万
-
财政年份:1993
-
负责人:Arthur M. BUCHBERG
-
依托单位:
INVOLVEMENT OF THE EVI-2 LOCUS IN MYELOID LEUKEMIA
-
批准号:3202730
-
项目类别:
-
资助金额:$17.63万
-
财政年份:1993
-
负责人:Arthur M. BUCHBERG
-
依托单位:
INVOLVEMENT OF THE EVI-2 LOCUS IN MYELOID LEUKEMIA
-
批准号:2099260
-
项目类别:
-
资助金额:$19.11万
-
财政年份:1993
-
负责人:Arthur M. BUCHBERG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: